SBEDGE

SBEdge is a systems biology-driven biotechnology company that specializes in computational modeling and simulation to accelerate drug discovery and development. The company utilizes advanced mathematical models to create "Virtual Patients" and simulate biological pathways, allowing for better prediction of drug efficacy and toxicity. By integrating high-throughput data with mechanistic models, SBEdge helps pharmaceutical partners optimize lead selection and clinical trial design. Their proprietary Taxila platform leverages artificial intelligence to extract insights from vast biological datasets, supporting biomarker discovery and drug repositioning. SBEdge's expertise spans various therapeutic areas, including oncology, immunology, and metabolic diseases, providing critical decision-support tools for the life sciences industry.